Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?
(2017) Current Hypertension Reports — Vol. 19, n° 1, p. 5 [1-21] (2017)
Files
VanderNiepenetalRAS-RHTN-CHR2017.pdf
Restricted Access - Adobe PDF
- 1.56 MB
Details
- Authors
- Abstract
- (en) After three large neutral trials in which renal artery revascularization failed to reduce cardiovascular and renal morbidity and mortality, renal artery stenting became a therapeutic taboo. However, this is probably unjustified as these trials have important limitations and excluded patients most likely to benefit from revascularization. In particular, patients with severe hypertension were often excluded and resistant hypertension was either poorly described or not conform to the current definition. Effective pharmacological combination treatment can control blood pressure in most patients with renovascular hypertension. However, it may also induce further renal hypoperfusion and thus accelerate progressive loss of renal tissue. Furthermore, case reports of patients with resistant hypertension showing substantial blood pressure improvement after successful revascularization are published over again. To identify those patients who would definitely respond to renal artery stenting, properly designed randomized clinical trials are definitely needed.
- Affiliations
Citations
Van der Niepen, P., Rossignol, P., Lengelé, J.-P., Berra, E., Sarafidis, P., & Persu, A. (2017). Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not? Current Hypertension Reports, 19(1), 5 [1-21]. https://doi.org/10.1007/s11906-017-0703-8 (Original work published 2017)